Pharmacokinetics of oral indoramin.
A randomized crossover study was carried out in 7 healthy subjects to investigate the pharmacokinetics of indoramin from two oral formulations (film-coated and uncoated 50 mg tablets) and to determine the effect of a standard mean on the plasma concentration time curve of the film-coated form. The results indicated that peak plasma concentrations occurred in 1 to 4 hours after treatment with a single dose of 2 tablets, with an overall elimination half-life of 5 hours. No significant differences could be shown between treatments in any of the pharmacokinetic variables determined. However, administration of film-coated indoramin after a standard meal narrowed the range of peak concentrations but the time at which peak concentrations of the drug occurred did not appear to be related to whether or not indoramin was given after the meal.
D000284:Administration, Oral; D000328:Adult; D006207:Half-Life; D006801:Humans; D007211:Indoles / Q000097:blood*; D007217:Indoramin / Q000097:blood*; D007408:Intestinal Absorption; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D013608:Tablets, Enteric-Coated
D007211:Indoles; D013608:Tablets, Enteric-Coated; D007217:Indoramin